CARILLON TOWER ADVISERS, INC. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$24,682,000
+16.6%
1,120,359
-4.8%
0.15%
-46.8%
Q3 2020$21,165,000
-25.6%
1,176,513
+5.0%
0.28%
+28.8%
Q2 2020$28,457,000
-99.9%
1,120,3590.0%0.22%
+15.3%
Q1 2020$19,415,821,000
-21.3%
1,120,3590.0%0.19%
+15.2%
Q4 2019$24,681,509,000
+153315.6%
1,120,3590.0%0.16%
+47.3%
Q3 2019$16,088,0001,120,3590.11%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$89,888,00013.40%
EcoR1 Capital, LLC 3,627,597$79,916,0007.20%
Aquilo Capital Management, LLC 614,436$13,536,0005.08%
RTW INVESTMENTS, LP 5,874,229$129,409,0004.88%
BRIDGER MANAGEMENT, LLC 1,981,633$43,655,0003.15%
ACUTA CAPITAL PARTNERS, LLC 387,500$8,537,0002.11%
Integral Health Asset Management, LLC 200,000$4,406,0001.72%
Burrage Capital Management LLC 104,047$2,292,0001.54%
Parkman Healthcare Partners LLC 240,000$5,287,0001.53%
EAM Global Investors LLC 122,237$2,693,0001.08%
View complete list of DICERNA PHARMACEUTICALS INC shareholders